Ryan Langston
Stock Analyst at TD Cowen
(2.97)
# 3,002
Out of 5,090 analysts
269
Total ratings
51.9%
Success rate
2.3%
Average return
Main Sectors:
Stocks Rated by Ryan Langston
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| EHC Encompass Health | Reiterated: Buy | $140 → $150 | $135.90 | +10.38% | 5 | Oct 30, 2026 | |
| CNC Centene | Reiterated: Hold | $65 | $68.45 | -5.04% | 19 | Oct 29, 2026 | |
| UHS Universal Health Services | Reiterated: Buy | $197 | $176.05 | +11.90% | 18 | Oct 29, 2026 | |
| HCA HCA Healthcare | Reiterated: Buy | $460 → $486 | $473.19 | +2.71% | 18 | Oct 28, 2026 | |
| ELV Elevance Health | Reiterated: Buy | $465 → $495 | $420.07 | +17.84% | 16 | Oct 23, 2026 | |
| DVA DaVita | Reiterated: Buy | $220 | $187.50 | +17.33% | 13 | Oct 21, 2026 | |
| UNH UnitedHealth Group | Reiterated: Hold | $402 | $406.97 | -1.22% | 20 | Oct 15, 2026 | |
| ALHC Alignment Healthcare | Reiterated: Buy | $21 → $12 | $7.27 | +65.06% | 11 | Oct 12, 2026 | |
| SGRY Surgery Partners | Rated: Buy | $19 | $23.21 | -18.14% | 13 | Sep 18, 2026 | |
| PIII P3 Health Partners | Reiterated: Hold | $13 | $4.03 | +222.58% | 12 | Aug 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $55 → $95 | $84.90 | +11.90% | 11 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $131 | $125.54 | +4.35% | 23 | Aug 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $350 → $370 | $414.50 | -10.74% | 16 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $36 | $29.96 | +20.16% | 16 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $230 → $200 | $204.78 | -2.33% | 19 | Jul 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $233 → $263 | $273.25 | -3.75% | 9 | Jul 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $45 → $50 | $36.53 | +36.87% | 13 | Jul 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $30 | $21.48 | +39.66% | 12 | May 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $391 → $333 | $298.23 | +11.66% | 4 | Feb 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $7 | $13.40 | n/a | 1 | Aug 9, 2024 |
Encompass Health
Oct 30, 2026
Reiterated: Buy
Price Target: $140 → $150
Current: $135.90
Upside: +10.38%
Centene
Oct 29, 2026
Reiterated: Hold
Price Target: $65
Current: $68.45
Upside: -5.04%
Universal Health Services
Oct 29, 2026
Reiterated: Buy
Price Target: $197
Current: $176.05
Upside: +11.90%
HCA Healthcare
Oct 28, 2026
Reiterated: Buy
Price Target: $460 → $486
Current: $473.19
Upside: +2.71%
Elevance Health
Oct 23, 2026
Reiterated: Buy
Price Target: $465 → $495
Current: $420.07
Upside: +17.84%
DaVita
Oct 21, 2026
Reiterated: Buy
Price Target: $220
Current: $187.50
Upside: +17.33%
UnitedHealth Group
Oct 15, 2026
Reiterated: Hold
Price Target: $402
Current: $406.97
Upside: -1.22%
Alignment Healthcare
Oct 12, 2026
Reiterated: Buy
Price Target: $21 → $12
Current: $7.27
Upside: +65.06%
Surgery Partners
Sep 18, 2026
Rated: Buy
Price Target: $19
Current: $23.21
Upside: -18.14%
P3 Health Partners
Aug 26, 2026
Reiterated: Hold
Price Target: $13
Current: $4.03
Upside: +222.58%
Aug 7, 2026
Reiterated: Hold
Price Target: $55 → $95
Current: $84.90
Upside: +11.90%
Aug 4, 2026
Rated: Buy
Price Target: $131
Current: $125.54
Upside: +4.35%
Jul 31, 2026
Rated: Hold
Price Target: $350 → $370
Current: $414.50
Upside: -10.74%
Jul 30, 2026
Reiterated: Buy
Price Target: $36
Current: $29.96
Upside: +20.16%
Jul 27, 2026
Rated: Hold
Price Target: $230 → $200
Current: $204.78
Upside: -2.33%
Jul 27, 2026
Rated: Buy
Price Target: $233 → $263
Current: $273.25
Upside: -3.75%
Jul 14, 2026
Rated: Buy
Price Target: $45 → $50
Current: $36.53
Upside: +36.87%
May 11, 2026
Reiterated: Buy
Price Target: $30
Current: $21.48
Upside: +39.66%
Feb 4, 2026
Reiterated: Buy
Price Target: $391 → $333
Current: $298.23
Upside: +11.66%
Aug 9, 2024
Rated: Hold
Price Target: $7
Current: $13.40
Upside: n/a